1. Home
  2. NNE vs LQDA Comparison

NNE vs LQDA Comparison

Compare NNE & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNE
  • LQDA
  • Stock Information
  • Founded
  • NNE 2022
  • LQDA 2004
  • Country
  • NNE United States
  • LQDA United States
  • Employees
  • NNE N/A
  • LQDA N/A
  • Industry
  • NNE
  • LQDA Biotechnology: Pharmaceutical Preparations
  • Sector
  • NNE
  • LQDA Health Care
  • Exchange
  • NNE NYSE
  • LQDA Nasdaq
  • Market Cap
  • NNE 1.2B
  • LQDA 1.3B
  • IPO Year
  • NNE 2024
  • LQDA 2018
  • Fundamental
  • Price
  • NNE $37.31
  • LQDA $13.17
  • Analyst Decision
  • NNE Strong Buy
  • LQDA Strong Buy
  • Analyst Count
  • NNE 2
  • LQDA 9
  • Target Price
  • NNE $58.00
  • LQDA $27.67
  • AVG Volume (30 Days)
  • NNE 5.6M
  • LQDA 3.0M
  • Earning Date
  • NNE 08-13-2025
  • LQDA 08-06-2025
  • Dividend Yield
  • NNE N/A
  • LQDA N/A
  • EPS Growth
  • NNE N/A
  • LQDA N/A
  • EPS
  • NNE N/A
  • LQDA N/A
  • Revenue
  • NNE N/A
  • LQDA $14,144,000.00
  • Revenue This Year
  • NNE N/A
  • LQDA $185.38
  • Revenue Next Year
  • NNE N/A
  • LQDA $350.95
  • P/E Ratio
  • NNE N/A
  • LQDA N/A
  • Revenue Growth
  • NNE N/A
  • LQDA N/A
  • 52 Week Low
  • NNE $6.30
  • LQDA $8.26
  • 52 Week High
  • NNE $48.05
  • LQDA $19.41
  • Technical
  • Relative Strength Index (RSI)
  • NNE N/A
  • LQDA 36.80
  • Support Level
  • NNE N/A
  • LQDA $13.60
  • Resistance Level
  • NNE N/A
  • LQDA $14.63
  • Average True Range (ATR)
  • NNE 0.00
  • LQDA 0.96
  • MACD
  • NNE 0.00
  • LQDA -0.40
  • Stochastic Oscillator
  • NNE 0.00
  • LQDA 0.46

About NNE NANO NUCLEAR ENERGY INC

Nano Nuclear Energy Inc is an early-stage nuclear energy company developing smaller, cheaper, and safer portable clean energy solutions. It is focused on four business lines as part of development-Micro Nuclear Reactor Business is developing the next-generation nuclear microreactors, in particular ZEUS, a solid core battery reactor, and ODIN, a low-pressure salt coolant reactor; Fuel Processing Business; Fuel Fabrication Business; Fuel Transportation Business, and Nuclear Consultation Services.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

Share on Social Networks: